Doctor profile · Federal record
Dr. Ruth Ann Vleugels, MD
Dermatology Physician (CMS: Dermatology) · Boston, MA
- NPI 1124154554
- Accepts Medicare
- 22 yrs in practice
- Female
- Group practice
- No sanctions
Practice & contact
- Primary practice
-
221 Longwood Ave
Boston, MA 021155804
(617) 732-4918 - Mailing address
-
111 Cypress St
Brookline, MA 024456002
Credentials & registration
- NPI registered
- February 2007 — 19 yrs on file
- Profile last updated
- July 18, 2012
- Year of graduation
- 2004 — 22 yrs since
- Specialty taxonomy
- 207N00000X — NUCC code
- State license (1)
- Massachusetts #236012
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1124154554. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
2,394
Distinct HCPCS
10
Medicare allowed
$129,021
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
17003 |
Destruction of precancer skin growth, 2-14 growths | 1,121 | 175 | $2 | |
99214 |
Established patient office or other outpatient visit, 30-39 minutes | 585 | 332 | $104 | |
17000 |
Destruction of precancer skin growth, 1 growth | 317 | 230 | $58 | |
99215 |
Established patient office or other outpatient visit, 40-54 minutes | 206 | 89 | $152 | |
17004 |
Destruction of precancer skin growth, 15 or more growths | 57 | 37 | $109 | |
11102 |
Biopsy of related skin growth, first growth | 28 | 28 | $26 | |
17262 |
Destruction of cancer skin growth of trunk, arms, or legs, 1.1-2.0 cm | 23 | 22 | $121 | |
17110 |
Destruction of skin growth, 1-14 growths | 18 | 17 | $76 | |
99204 |
New patient office or other outpatient visit, 45-59 minutes | 14 | 14 | $142 | |
99205 |
New patient office or other outpatient visit, 60-74 minutes | 13 | 13 | $193 |
In context: peer comparison
Among 69 peers in Boston Dermatology Physician, average services per provider: 115. This provider delivers 21× the peer median.Open Payments
Industry payments received
All-time total
$99,039
Transactions
60
Manufacturers
10
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| AstraZeneca Uk Limited | 5 | $24,625.09 | |
| Lilly USA, LLC | 12 | $24,061.84 | |
| Eli Lilly and Company | 10 | $18,646.59 | |
| E.R. Squibb & Sons, L.L.C. | 10 | $14,487.85 | |
| Abbvie INC. | 14 | $10,779.97 | |
| Janssen Biotech, INC. | 3 | $3,368.48 | |
| Amgen INC. | 3 | $2,090.50 | |
| Almirall LLC | 1 | $800.00 | |
| Sun Pharmaceutical Industries INC. | 1 | $147.24 | |
| Arcutis Biotherapeutics, INC. | 1 | $31.71 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
704
Patients
133
Total drug cost
$4,432,224
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Octagam (Immun Globg(Igg)/Malt/Iga Ov50) | Brand | 89 | 0 | $1,667,133 |
| Panzyga (Immun Glob G(Igg)-Ifas/Glycine) | Brand | 80 | 0 | $1,382,389 |
| Dupixent Syringe (Dupilumab) | Brand | 74 | 0 | $345,473 |
| Methotrexate (Methotrexate Sodium) | Brand | 62 | 21 | $2,844 |
| Mycophenolate Mofetil | Generic | 52 | 15 | $14,310 |
| Hydroxychloroquine Sulfate | Generic | 44 | 15 | $3,949 |
| Triamcinolone Acetonide | Generic | 41 | 30 | $627 |
| Gamunex-C (Immune Globul G/Gly/Iga Avg 46) | Brand | 39 | 0 | $344,295 |
| Ketoconazole | Generic | 38 | 19 | $1,910 |
| Clobetasol Propionate | Generic | 36 | 20 | $1,987 |
Hospital affiliations
Frequently asked questions
What is Dr. Ruth Ann Vleugels's medical specialty?
Dr. Ruth Ann Vleugels practices Dermatology Physician in Boston, MA.
Where does Dr. Ruth Ann Vleugels practice?
Dr. Ruth Ann Vleugels practices at 221 Longwood Ave, Boston, MA 021155804. Office phone: 6177324918.
What is Dr. Ruth Ann Vleugels's NPI?
Dr. Ruth Ann Vleugels's National Provider Identifier (NPI) is 1124154554, issued by NPPES.
Does Dr. Ruth Ann Vleugels accept Medicare assignment?
Yes. Dr. Ruth Ann Vleugels accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Ruth Ann Vleugels commonly perform?
Top Medicare-reported procedures in 2023: Destruction of precancer skin growth, 2-14 growths (HCPCS 17003); Established patient office or other outpatient visit (HCPCS 99214); Destruction of precancer skin growth, 1 growth (HCPCS 17000). Source: CMS Medicare Physician & Other Practitioners file.